SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,387 | -80.7% | 393,405 | +25.1% | 0.00% | – |
| Q2 2023 | $375,714 | +72.9% | 314,405 | 0.0% | 0.00% | – |
| Q1 2023 | $217,317 | -49.1% | 314,405 | -50.0% | 0.00% | – |
| Q4 2022 | $426,962 | +31.8% | 628,810 | +100.0% | 0.00% | – |
| Q3 2022 | $324,000 | +51.4% | 314,405 | 0.0% | 0.00% | – |
| Q2 2022 | $214,000 | -85.4% | 314,405 | -82.0% | 0.00% | – |
| Q1 2022 | $1,462,000 | -46.0% | 1,745,269 | +5.1% | 0.00% | – |
| Q4 2021 | $2,706,000 | -28.9% | 1,660,304 | +5.1% | 0.00% | – |
| Q3 2021 | $3,807,000 | +22.5% | 1,579,863 | +34.1% | 0.00% | – |
| Q2 2021 | $3,109,000 | – | 1,177,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENDELL JEFFREY L | 4,908,725 | $5,056,000 | 0.66% |
| Uniplan Investment Counsel, Inc. | 2,485,327 | $2,559,000 | 0.20% |
| Oasis Management Co Ltd. | 850,000 | $876,000 | 0.15% |
| AdvisorShares Investments LLC | 470,151 | $484,000 | 0.13% |
| 1492 Capital Management LLC | 99,819 | $103,000 | 0.07% |
| Sovereign Financial Group, Inc. | 75,000 | $77,000 | 0.03% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 45,500 | $47,000 | 0.03% |
| MAI Capital Management | 1,230,810 | $1,268,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 137,266 | $141,000 | 0.02% |
| FORTEM FINANCIAL GROUP, LLC | 20,000 | $21,000 | 0.02% |